Malignant Purkinje ectopy induced by sodium channel blockers.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
10 2022
Historique:
received: 20 12 2021
revised: 27 06 2022
accepted: 29 06 2022
pubmed: 15 7 2022
medline: 5 10 2022
entrez: 14 7 2022
Statut: ppublish

Résumé

Sodium channel blocker (SCB) infusion is used to unmask the electrocardiographic pattern of Brugada syndrome. The test may also induce premature ventricular complexes (PVCs) in individuals without Brugada pattern, the clinical relevance of which is little known. The purpose of this study was to describe the prevalence of short-coupled (Sc) PVCs induced by ajmaline or flecainide in patients with suspected or documented severe ventricular arrhythmias. We reviewed the SCB tests performed in 335 patients with suspected ventricular arrhythmias and structurally normal hearts in 9 centers. ScPVCs were defined as frequent and repetitive PVCs with an R-on-T pattern on SCB tests. Repeated SCB tests were performed in 7 patients and electrophysiological mapping of ScPVCs in 9. Sixteen patients (8 men; mean age 36 ± 11 years) showed ScPVCs and were included. ScPVCs appeared 229 ± 118 seconds after the initiation of infusion and displayed coupling intervals of 288 ± 28 ms. ScPVC patterns were monomorphic in 12 patients, originating from the Purkinje system in mapped patients. Repetitive PVCs were induced in 15 patients (94%) including polymorphic ventricular tachycardias in 9 (56%). SCB infusion was repeated 45 (interquartile range 0.6-46) months later and induced identical ScPVC in all. SCB test was the only mean to reveal the malignant arrhythmia in 6 patients. Catheter ablation was performed in 9 patients, resulting in arrhythmia elimination in 8 with a follow-up of 6 (interquartile range 2-9) years. SCB can induce ScPVC, mostly from Purkinje tissue, in a small subset of patients with idiopathic ventricular arrhythmias. Its high reproducibility suggests a distinct individual mechanism.

Sections du résumé

BACKGROUND
Sodium channel blocker (SCB) infusion is used to unmask the electrocardiographic pattern of Brugada syndrome. The test may also induce premature ventricular complexes (PVCs) in individuals without Brugada pattern, the clinical relevance of which is little known.
OBJECTIVE
The purpose of this study was to describe the prevalence of short-coupled (Sc) PVCs induced by ajmaline or flecainide in patients with suspected or documented severe ventricular arrhythmias.
METHODS
We reviewed the SCB tests performed in 335 patients with suspected ventricular arrhythmias and structurally normal hearts in 9 centers. ScPVCs were defined as frequent and repetitive PVCs with an R-on-T pattern on SCB tests. Repeated SCB tests were performed in 7 patients and electrophysiological mapping of ScPVCs in 9.
RESULTS
Sixteen patients (8 men; mean age 36 ± 11 years) showed ScPVCs and were included. ScPVCs appeared 229 ± 118 seconds after the initiation of infusion and displayed coupling intervals of 288 ± 28 ms. ScPVC patterns were monomorphic in 12 patients, originating from the Purkinje system in mapped patients. Repetitive PVCs were induced in 15 patients (94%) including polymorphic ventricular tachycardias in 9 (56%). SCB infusion was repeated 45 (interquartile range 0.6-46) months later and induced identical ScPVC in all. SCB test was the only mean to reveal the malignant arrhythmia in 6 patients. Catheter ablation was performed in 9 patients, resulting in arrhythmia elimination in 8 with a follow-up of 6 (interquartile range 2-9) years.
CONCLUSION
SCB can induce ScPVC, mostly from Purkinje tissue, in a small subset of patients with idiopathic ventricular arrhythmias. Its high reproducibility suggests a distinct individual mechanism.

Identifiants

pubmed: 35835363
pii: S1547-5271(22)02169-5
doi: 10.1016/j.hrthm.2022.06.034
pii:
doi:

Substances chimiques

Sodium Channel Blockers 0
Ajmaline 1PON08459R
Flecainide K94FTS1806

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1595-1603

Informations de copyright

Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

William Escande (W)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.

Jean-Baptiste Gourraud (JB)

L'Institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France; CHU Nantes, Service de génétique médicale, Nantes, France.

Michel Haissaguerre (M)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France; Bordeaux University, CRCTB U1045, Inserm, Bordeaux, France. Electronic address: michel.haissaguerre@chu-bordeaux.fr.

Estelle Gandjbakhch (E)

Pitié-Salpêtrière University Hospital, Institute of Cardiology, Paris, France.

Thomas Lavergne (T)

Cardiology Department, Rhythmology Unit, Hôpital Européen Georges Pompidou, Paris, France.

Raphael Martins (R)

Cardiology Department, Rennes University Hospital, Rennes, France.

Ghassen Cheniti (G)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.

Philipp Krisai (P)

Department of Cardiology, University Hospital Basel, Basel, Switzerland.

Jean Sylvain Hermida (JS)

Centre Hospitalier Universitaire d'Amiens-Picardie, Amiens, France.

Philippe Maury (P)

Department of Cardiology, University Hospital Rangueil, Toulouse, France.

Jose-Louis Merino (JL)

Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.

Jean-Luc Pasquié (JL)

Département de Cardiologie, CHRU Montpellier, Montpellier, France.

Nicolas Combes (N)

Department of Cardiology, Clinique Pasteur, Toulouse, France.

Elodie Surget (E)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.

Josselin Duchateau (J)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.

Thomas Pambrun (T)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.

Nicolas Derval (N)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.

Mélèze Hocini (M)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.

Pierre Jaïs (P)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.

Pieter G Postema (PG)

Department of Clinical and Experimental Cardiology, Heart Center, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Koonlawee Nademanee (K)

Chulalongkorn University, Faculty of Medicine, and Pacific Rim Electrophysiology Research Institute at Bumrungrad Hospital, Bangkok, Thailand.

Ed Vigmond (E)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France; University of Bordeaux, IMB, UMR 5251, Talence, France.

Olivier Bernus (O)

IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France; Bordeaux University, CRCTB U1045, Inserm, Bordeaux, France.

Frederic Sacher (F)

Department of Electrophysiology and Cardiac Pacing, Bordeaux University Hospital, Bordeaux, France; IHU LIRYC, Electrophysiology and Heart Modeling Institute, Bordeaux, France.

Vincent Probst (V)

L'Institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France; CHU Nantes, Service de génétique médicale, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH